Burcin Fraser
Allergy · Chevy Chase, MDNPI 1548444078
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 297 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,589, 2.1 times the $749 reported in 2019. That places this record below the midpoint for allergy clinicians in MD, where the typical reported total is $7,148.
Across 297 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$814
- AstraZeneca$729
- Sanofi$717
- Takeda Pharmaceuticals U.S.A., Inc.$511
- Kaleo, Inc.$345
- plus $2K from 29 others
What the payments were for
- Consulting fees$411%
- Food & beverage$6,46599%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 57 | $1,007 |
| Regeneron Healthcare Solutions, Inc. | 31 | $814 |
| AstraZeneca | 39 | $729 |
| Sanofi | 27 | $717 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $511 |
| Kaleo, Inc. | 14 | $345 |
| Pfizer | 15 | $279 |
| Genentech USA, Inc. | 11 | $268 |
| Grifols USA, LLC | 9 | $204 |
| Optinose US, Inc. | 10 | $184 |
| Biocryst US Sales Co., LLC | 6 | $136 |
| Shire North American Group Inc | 6 | $124 |
| Pharming Healthcare, Inc. | 5 | $117 |
| Novartis | 5 | $115 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $110 |
| Octapharma USA, Inc. | 1 | $106 |
| CSL Behring | 4 | $90 |
| Amgen(2 entities) | 4 | $73 |
| Lilly USA, LLC | 3 | $66 |
| Phadia US Inc. | 3 | $57 |
| Aimmune Therapeutics, Inc. | 3 | $56 |
| Galderma Laboratories, L.p. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| ADMA Biomanufacturing LLC | 2 | $41 |
| Alk-abello, Inc | 2 | $41 |
| Aytu Biopharma, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| Aerin Medical Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $27 |
| Covis Pharma GmbH | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Biocryst Pharmaceuticals, Inc. | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Bio Products Laboratory USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CUTAQUIG$106
How this compares
$6,521 in reported general payments places this provider in the 45th percentile of 29 allergy providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Chevy Chase
- Huamin LiWheaton$576K
- David GoldenBaltimore$197K
- Jody TverskyBaltimore$175K
- Sarbjit SainiBaltimore$174K
- Jonathan MatzWhite Marsh$147K
- Newton AdkinsonBaltimore$61K
- Brett CoonsJb Andrews$49K
- Peter CreticosBaltimore$22K
- David SchwartzBethesda$15K
- Asek MakiaMitchellville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.